Sec Form 4 Filing - Myers Jason W. @ Invitae Corp - 2020-10-02

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Myers Jason W. 2. Issuer Name and Ticker or Trading Symbol Invitae Corp [ NVTA] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) X __ Other (specify below) President, Oncology (Last) (First) (Middle) C/O INVITAE CORPORATION, 1400 16TH STREET 3. Date of Earliest Transaction (MM/DD/YY) 10/02/2020 (Street) SAN FRANCISCO, CA94103 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 10/02/2020 A 1,039,227 A 1,039,227 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (right to buy) $ 0.86 10/02/2020 A 278,417 ( 3 ) 10/01/2028 Common Stock 278,417 ( 1 ) ( 4 ) 278,417 D Stock Option (right to buy) $ 3.77 10/02/2020 A 643,839 ( 3 ) 12/16/2029 Common Stock 643,839 ( 1 ) ( 5 ) 643,839 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Myers Jason W. C/O INVITAE CORPORATION 1400 16TH STREET SAN FRANCISCO, CA94103 X President, Oncology Signatures /s/ Jason W. Myers 10/05/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Received pursuant to the Agreement and Plan of Merger and Plan of Reorganization, dated as of June 21, 2020, by and among the Issuer, Apollo Merger Sub A Inc., a wholly-owned, direct subsidiary of the Issuer ("Merger Sub A"), Apollo Merger Sub B LLC, a wholly-owned, direct subsidiary of the Issuer ("Merger Sub B"), ArcherDX, Inc. ("ArcherDX"), and Kyle Lefkoff, solely in his capacity as holders' representative, pursuant to which ArcherDX merged with and into Merger Sub A, with ArcherDX surviving the merger as a wholly-owned subsidiary of the Issuer and immediately after such merger, ArcherDX merged with and into Merger Sub B with Merger Sub B surviving the merger as a wholly-owned subsidiary of the Issuer. ( 2 )Received in exchange for 374,578 shares of ArcherDX common stock and 676,379 shares of ArcherDX preferred stock. ( 3 )Option is fully vested and exercisable. ( 4 )Received in exchange for an option to acquire 281,560 shares of ArcherDX common stock. ( 5 )Received in exchange for an option to acquire 651,107 shares of ArcherDX common stock.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.